ArticleProtein science : a publication of the Protein Society2026
Substrate selectivity of human histidine methyltransferase METTL9.
Article in Protein science : a publication of the Protein Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Decoding Protein-Methylating METTLs in Humans: Structural, Functional, and Disease Insights over the Past Decade.International journal of molecular sciences · 2026Review
- Histidine Ethylation by Histidine Methyltransferases SETD3 and METTL9.Chembiochem : a European journal of chemical biology · 2026Article
- Substrate selectivity of human histidine methyltransferase METTL9.Protein science : a publication of the Protein Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Methylation of histidine residues in zinc transporters by histidine methyltransferase METTL9 plays an important role in modulating their metal-binding properties. Here, we report synthetic, enzymatic, and computational studies on human METTL9-catalyzed Nπ-methylation of His375 in zinc transporter SLC39A5-derived peptides in which the histidine substrate and its neighboring residues are substituted by chemically and structurally diverse proteinogenic and nonproteinogenic amino acids. Our work reveals that the xHxH motif (residues 372-375) is essential for efficient Nπ-histidine methyltransferase METTL9 catalysis. We demonstrate that human METTL9 has an exceptionally narrow substrate scope towards His375 and does not catalyze methylation of simple histidine mimics in the SLC39A5 peptide. Moreover, METTL9 recognizes only 2-pyridylalanine, 3-(4-thiazolyl)alanine and backbone N-methylated histidine residues at position 373 in addition to the natural His373 residue. METTL9 has also a capacity to recognize a few simplest mimics of Ser374 and Gly372 residues in the SLC39A5 sequence. Molecular dynamics simulations support the experimental findings and deliver a comprehensive structural basis on the significance of the xHxH motif for stable METTL9-SLC39A5 complex formation and efficient METTL9 catalysis. Overall, this study provides evidence for different substrate selectivities of human histidine methyltransferase METTL9, the knowledge important from basic molecular and biomedical perspectives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.